4D Molecular Therapeutics Statistics
Total Valuation
FDMT has a market cap or net worth of $1.31 billion. The enterprise value is $795.32 million.
| Market Cap | 1.31B |
| Enterprise Value | 795.32M |
Important Dates
The last earnings date was Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
FDMT has 51.70 million shares outstanding. The number of shares has increased by 50.57% in one year.
| Shares Outstanding | 51.70M |
| Shares Change (YoY) | +50.57% |
| Shares Change (QoQ) | +14.94% |
| Owned by Insiders (%) | 3.50% |
| Owned by Institutions (%) | 110.44% |
| Float | 30.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 63.91 |
| Forward PS | 390.48 |
| PB Ratio | 2.18 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 38.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 32.65, with a Debt / Equity ratio of 0.02.
| Current Ratio | 32.65 |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -26.70% and return on invested capital (ROIC) is -19.67%.
| Return on Equity (ROE) | -26.70% |
| Return on Assets (ROA) | -24.80% |
| Return on Capital (ROIC) | -19.67% |
| Revenue Per Employee | $139,129 |
| Profits Per Employee | -$711,265 |
| Employee Count | 147 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +39.38% in the last 52 weeks. The beta is 2.93, so FDMT's price volatility has been higher than the market average.
| Beta (1Y) | 2.93 |
| 52-Week Price Change | +39.38% |
| 50-Day Moving Average | 27.83 |
| 200-Day Moving Average | 19.74 |
| Relative Strength Index (RSI) | 44.43 |
| Average Volume (30 Days) | 635,166 |
Short Selling Information
The latest short interest is 9.62 million, so 18.61% of the outstanding shares have been sold short.
| Short Interest | 9.62M |
| Short Previous Month | 9.83M |
| Short % of Shares Out | 18.61% |
| Short % of Float | 31.16% |
| Short Ratio (days to cover) | 16.44 |
Income Statement
In the last 12 months, FDMT had revenue of $20.45 million and -$104.56 million in losses. Loss per share was -$2.44.
| Revenue | 20.45M |
| Gross Profit | 20.45M |
| Operating Income | -120.90M |
| Pretax Income | -104.56M |
| Net Income | -104.56M |
| EBITDA | -98.63M |
| EBIT | -104.56M |
| Loss Per Share | -$2.44 |
Balance Sheet
The company has $525.91 million in cash and $14.17 million in debt, giving a net cash position of $511.74 million or $9.90 per share.
| Cash & Cash Equivalents | 525.91M |
| Total Debt | 14.17M |
| Net Cash | 511.74M |
| Net Cash Per Share | $9.90 |
| Equity / Book Value | 600.56M |
| Book Value Per Share | 11.62 |
| Working Capital | 519.19M |
Cash Flow
In the last 12 months, operating cash flow was -$76.97 million and capital expenditures -$2.47 million, giving a free cash flow of -$79.44 million.
| Operating Cash Flow | -76.97M |
| Capital Expenditures | -2.47M |
| Free Cash Flow | -79.44M |
| FCF Per Share | -$1.61 |
Margins
Gross margin is 100.00%, with operating and profit margins of -591.13% and -511.23%.
| Gross Margin | 100.00% |
| Operating Margin | -591.13% |
| Pretax Margin | -511.23% |
| Profit Margin | -511.23% |
| EBITDA Margin | -482.23% |
| EBIT Margin | -511.23% |
| FCF Margin | -388.44% |
Dividends & Yields
FDMT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -50.57% |
| Shareholder Yield | -50.57% |
| Earnings Yield | -8.00% |
| FCF Yield | -6.08% |
Analyst Forecast
The average price target for FDMT is $46.56, which is 83.74% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $46.56 |
| Price Target Difference | 83.74% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 61.68% |
| EPS Growth Forecast (5Y) | 0.24% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FDMT has an Altman Z-Score of 26.22 and a Piotroski F-Score of 4.
| Altman Z-Score | 26.22 |
| Piotroski F-Score | 4 |